Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Short-Term Debt issuances (2017)

vTv Therapeutics (VTVT) has disclosed Short-Term Debt issuances for 1 consecutive years, with $7.5 million as the latest value for Q1 2017.

  • Quarterly Short-Term Debt issuances changed N/A to $7.5 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2017, changed N/A year-over-year, with the annual reading at $7.5 million for FY2017, 40.0% down from the prior year.
  • Short-Term Debt issuances hit $7.5 million in Q1 2017 for vTv Therapeutics.
  • In the past five years, Short-Term Debt issuances ranged from a high of $7.5 million in Q1 2017 to a low of $7.5 million in Q1 2017.